Once considered to be a promising birth control option for women, Bayer’s popular drugs, Yaz, Yasmin and Ocella have since fallen under intense scrutiny and remain a major subject of concern among the U.S. Food and Drug Administration, as well as within pharmaceutical advocacy groups like the U.S. Drug Watchdog.
While it is understood that the formation of blood clots is a potential side effect for women taking any form of birth control, four major studies have now proven that women taking Yaz, Yasmin and Ocella are 2 to 3 times more likely to develop clots, compared to women taking older generation, non-drospirenone containing pills.
The U.S. Drug Watchdog has declared that educating women regarding the harmful side effects associated with the use of Yaz, Yasmin and Ocella has become their “most important women’s health initiative ever.” The group is encouraging those who have suffered or have a loved-one who has suffered from stroke, heart attack, deep vein thrombosis, pulmonary embolism or even sudden death while taking these drug therapies to come forward.
Even more alarming, many women are being prescribed these particular medications for purposes other than birth control. For example, some women are given the drugs as a treatment for acne or as a reliever of PMDD symptoms. None of these drugs have been FDA approved for use as a treatment for either of these conditions.
In fact, as a response to such concerns, the FDA has commissioned a study of 800,000 American women currently using oral contraceptives in order to accurately assess the real danger associated with use of these drugs.